Search research articles
Contact Us
Filters
Showing results (131-140 of 179) with videos related to
Page
of 18
Sort By:
The New England Journal of Medicine
|
September 15, 2017
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R Holman, M Angelyn Bethel, Robert J Mentz, et al.
Journal of Hypertension
|
August 19, 2022
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension
George Stergiou, Mattias Brunström, Thomas MacDonald, et al.
International Journal of Cardiology
|
October 23, 2013
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration
Ruth Webster, Anushka Patel, Laurent Billot, et al.
American Heart Journal
|
May 26, 2018
Rationale and design of the comparison of 3 combination therapies in lowering blood pressure in black Africans (CREOLE study): 2 × 3 factorial randomized single-blind multicenter trial
Dike B Ojji, Neil Poulter, Albertino Damasceno, et al.
Eclinicalmedicine
|
October 29, 2024
The NITRATE-OCT study-inorganic nitrate reduces in-stent restenosis in patients with stable coronary artery disease: a double-blind, randomised controlled trial
Krishnaraj S Rathod, Anthony Mathur, Asad Shabbir, et al.
The New England Journal of Medicine
|
June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
, Anushka Patel, Stephen MacMahon, et al.
BMJ Open
|
November 18, 2017
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
Michael Alan Glaysher, Aruchuna Mohanaruban, Christina Gabriele Prechtl, et al.
American Heart Journal
|
March 21, 2016
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
Rury R Holman, Mary Angelyn Bethel, Jyothis George, et al.
Cardiovascular Journal of Africa
|
September 15, 2017
Roadmap to achieve 25% hypertension control in Africa by 2025
Anastase Dzudie, Brian Rayner, Dike Ojji, et al.
Global Heart
|
October 19, 2017
Roadmap to Achieve 25% Hypertension Control in Africa by 2025
Anastase Dzudie, Brian Rayner, Dike Ojji, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 179) with videos related to
Sort By:
Page
of 18
The New England Journal of Medicine
|
September 15, 2017
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
Rury R Holman, M Angelyn Bethel, Robert J Mentz, et al.
Journal of Hypertension
|
August 19, 2022
Bedtime dosing of antihypertensive medications: systematic review and consensus statement: International Society of Hypertension position paper endorsed by World Hypertension League and European Society of Hypertension
George Stergiou, Mattias Brunström, Thomas MacDonald, et al.
International Journal of Cardiology
|
October 23, 2013
Prospective meta-analysis of trials comparing fixed dose combination based care with usual care in individuals at high cardiovascular risk: the SPACE Collaboration
Ruth Webster, Anushka Patel, Laurent Billot, et al.
American Heart Journal
|
May 26, 2018
Rationale and design of the comparison of 3 combination therapies in lowering blood pressure in black Africans (CREOLE study): 2 × 3 factorial randomized single-blind multicenter trial
Dike B Ojji, Neil Poulter, Albertino Damasceno, et al.
Eclinicalmedicine
|
October 29, 2024
The NITRATE-OCT study-inorganic nitrate reduces in-stent restenosis in patients with stable coronary artery disease: a double-blind, randomised controlled trial
Krishnaraj S Rathod, Anthony Mathur, Asad Shabbir, et al.
The New England Journal of Medicine
|
June 10, 2008
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
, Anushka Patel, Stephen MacMahon, et al.
BMJ Open
|
November 18, 2017
A randomised controlled trial of a duodenal-jejunal bypass sleeve device (EndoBarrier) compared with standard medical therapy for the management of obese subjects with type 2 diabetes mellitus
Michael Alan Glaysher, Aruchuna Mohanaruban, Christina Gabriele Prechtl, et al.
American Heart Journal
|
March 21, 2016
Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial
Rury R Holman, Mary Angelyn Bethel, Jyothis George, et al.
Cardiovascular Journal of Africa
|
September 15, 2017
Roadmap to achieve 25% hypertension control in Africa by 2025
Anastase Dzudie, Brian Rayner, Dike Ojji, et al.
Global Heart
|
October 19, 2017
Roadmap to Achieve 25% Hypertension Control in Africa by 2025
Anastase Dzudie, Brian Rayner, Dike Ojji, et al.
Page
of 18